Evolus (EOLS) Misses Q2 EPS by 13c ; Offers Guidance

Evolus (NASDAQ: EOLS) reported Q2 EPS of ($0.18), $0.13 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $66.9 million versus the consensus estimate of $64.93 million.

GUIDANCE:

Evolus sees FY2024 revenue of $260-270 million, versus the consensus of $262.2 million.

For earnings history and earnings-related data on Evolus (EOLS) click here.

You May Also Be Interested In

• Goldman Sachs (GS) Reiterated at Market Perform by Citizens on Constructive Backdrop
• Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
• RBC Capital Upgrades ICON plc (ICLR) to Outperform